In Brief
This article was originally published in The Tan Sheet
Executive Summary
Watson acquires Australian OTC firm; childproof packaging for imidazoline; Supplement Facts box update delayed; more news In Brief
You may also be interested in...
CHPA Requests Extension To Childproof Imidazoline Product Packaging
The OTC trade group says firms need two years, twice the time CPSC would allow under a proposed rule, to require child-resistant packaging for drugs with more than 0.08 mg of imidazolines, including such OTCs as Visine eye drops and Afrin nasal decongestants.
CHPA Requests Extension To Childproof Imidazoline Product Packaging
The OTC trade group says firms need two years, twice the time CPSC would allow under a proposed rule, to require child-resistant packaging for drugs with more than 0.08 mg of imidazolines, including such OTCs as Visine eye drops and Afrin nasal decongestants.
People In Brief
Himmel named ChromaDex CEO; Pinney reorganizes senior management; FDA vet Chappell jumps to Greenleaf; more People In Brief.